Law Firm Of Levi & Korsinsky, LLP Announces Class Action Against DGSE Companies Inc. (DGSE), Body Central Corp. (BODY) And Vertex Pharmaceuticals Inc. (VRTX) And Investigation Of Mediware Information Systems, Inc. (MEDW)
NEW YORK, Sept. 24, 2012 /PRNewswire/ --
DGSE Companies Inc.Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Northern District of Texas on behalf of investors who purchased DGSE Companies Inc. (NYSE MKT: DGSE) stock between April 15, 2011 and April 17, 2012.
For more information, click here: http://zlk.9nl.com/dgse-companies-dgse . You have until November 6, 2012 to request that the Court appoint you as lead plaintiff.
Body Central Corporation Levi & Korsinsky announces that a class action lawsuit has been commenced in the S District Court for the Middle District of Florida on behalf of investors who purchased Body Central Corporation (NasdaqGS: BODY) securities between November 10, 2011 and June 18, 2012.For more information, click here: http://zlk.9nl.com/body-central-body . You have until October 29, 2012 to request that the Court appoint you as lead plaintiff. Vertex Pharmaceuticals IncorporatedLevi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX) securities between May 7, 2012 and June 27, 2012. For more information, click here: http://zlk.9nl.com/vertex-pharmaceuticals-vertex . You have until November 5, 2012 to request that the Court appoint you as lead plaintiff. Mediware Information Systems, Inc.Levi & Korsinsky is investigating the Board of Directors of Mediware Information Systems, Inc. (Nasdaq: MEDW) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Thoma Bravo, LLC. for $22.00 per share. Click here to learn more about the investigation: http://zlk.9nl.com/mediware-information-systems-medw , or call: 877-363-5972.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts